Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Cambridge NeuroScience announces advances in MS program

Sep. 2, 1998

Betaseron to receive fast track review in Canada

Sep. 2, 1998

Lamotrigine approved for new indication in the U.S.: Lennox-Gastaut syndrome

Sep. 2, 1998

PD-165167 shows excellent selectivity for dopamine D4 receptors

Sep. 1, 1998

Vertex, Schering AG form strategic alliance to develop neurologic drugs

Aug. 31, 1998

Orion and Novartis agree on the distribution of entacapone

Aug. 31, 1998

Results of phase II study support efficacy of (S)-fluoxetine as a treatment for migraine

Aug. 31, 1998

News from the ACS: Lilly investigates antioxidants for treating neuronal injury

Aug. 28, 1998

News from the ACS: Roche synthesizes selective 5-HT2C antagonists

Aug. 28, 1998

Schwarz, Discovery Therapeutics collaborate on transdermal treatment for Parkinson's disease

Aug. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...